The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 10, 2023

Filed:

Apr. 06, 2020
Applicant:

Florida State University Research Foundation, Inc., Tallahassee, FL (US);

Inventor:

Teng Ma, Tallahassee, FL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/0775 (2010.01); C12N 5/00 (2006.01); A61K 35/28 (2015.01); C12M 1/26 (2006.01); C12M 1/12 (2006.01); C12M 3/04 (2006.01); C12M 3/06 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0663 (2013.01); A61K 35/28 (2013.01); C12M 25/16 (2013.01); C12M 27/10 (2013.01); C12M 27/16 (2013.01); C12M 33/00 (2013.01); C12N 5/0062 (2013.01); C12N 5/0075 (2013.01); C12N 2500/02 (2013.01); C12N 2500/42 (2013.01); C12N 2501/33 (2013.01); C12N 2501/39 (2013.01); C12N 2501/727 (2013.01); C12N 2501/998 (2013.01); C12N 2501/999 (2013.01); C12N 2509/00 (2013.01); C12N 2513/00 (2013.01); C12N 2527/00 (2013.01); C12N 2531/00 (2013.01); C12N 2533/30 (2013.01); C12N 2533/54 (2013.01); C12N 2533/70 (2013.01); C12N 2539/10 (2013.01);
Abstract

The subject invention concerns materials and methods for expansion of stem cells, such as mesenchymal stem cells (MSC), that improve translational success of the cells in the treatment of various conditions. The subject invention utilizes cell self-aggregation as a non-genetic means to enhance their therapeutic potency in a microcarrier bioreactor. In one embodiment of the method cells are cultured in a container or vessel in the presence of thermally responsive microcarriers (TRMs) wherein cells adhere to the surface of the TRMs. After a period of time the cell culture temperature is reduced so that the cells detach from the TRMs. The detached cells are allowed to form 3D aggregates. The 3D aggregates can be collected and treated to dissociate the cells. Dissociated cells can then be used for transplantation in methods of treatment or for in vitro characterization and study.


Find Patent Forward Citations

Loading…